Metabolic & Cardiometabolic
glucose variability predicts cardiovascular risk in non-diabetics
In plain terms: Does blood-sugar "variability" on a CGM predict heart disease in healthy people?
Variability tracks surrogate risk markers, but direct hard-outcome CV evidence in non-diabetics is limited, so the "predicts CVD" claim is not established.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Population patterns (Observational)
How the studies fall
The evidence (12)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Sato 2026 · J Clin Endocrinol Metab | observational | mixed | moderate | Lower CGM-derived time-in-range was longitudinally associated with worsening arterial stiffness, but in type 2 diabetes rather than non-diabetic subjects. |
| Jang 2019 · Sci Rep | observational | supports | moderate | In 6,462 nondiabetic adults under 65y, higher visit-to-visit HbA1c/fasting/post-load glucose variability was associated with increased macro- and microvascular events. |
| Sparks 2021 · Int J Environ Res Public Health | observational | tested-null | low | In overweight/obese non-diabetics, 12-wk exercise changed vascular/oxidative markers but CGM glycemic variability did NOT change — decoupling variability from vascular outcomes. |
| Liao 2026 · Eur J Med Res | meta-analysis | mixed | low | CGM in non-diabetic populations can modify glycemic and behavioral metrics, but the review found no hard-outcome data tying CGM-derived variability to cardiovascular events in healthy people. |
| Qian 2026 · Diabet Med | mechanism | mixed | low | A perspective argues glycemic variability drives endothelial damage and cardiovascular risk even in pre-diabetes, but this is framed as mechanism and hypothesis, not outcome evidence. |
| Wu 2025 · Front Endocrinol | meta-analysis | mixed | moderate | HbA1c variability was linked to incident CVD and mortality, but the association is established in type 2 diabetes, not in non-diabetic individuals. |
| Wilczek 2025 · Sensors (Basel) | observational | mixed | moderate | SR of CGM in non-diabetics: data scarce, effect on cardiovascular outcomes unclear; only potential/surrogate benefit, no hard-endpoint prediction demonstrated. |
| An 2021 · Eur Rev Med Pharmacol Sci | observational | supports | moderate | Visit-to-visit fasting blood sugar variability was associated with higher cardiovascular disease and mortality risk in a general population that was largely non-diabetic. |
| Liu 2022 · Diabetes Obes Metab | observational | mixed | moderate | Visit-to-visit glucose variability predicts all-cause mortality — but population is type 2 diabetes, not non-diabetics; not CGM-measured. |
| Ahmed 2025 · Cureus | observational | mixed | moderate | Systematic review (7 studies) in non-diabetics: higher glycemic variability linked to surrogate markers (e.g. BP variability) but direct evidence on hard cardiovascular endpoints remains limited. |
| Costantino 2017 · Diabetes | mechanism | supports | moderate | Glycemic variability drives chromatin remodeling, oxidative stress and endothelial dysfunction — but in type 2 diabetics at target HbA1c, not healthy people; mechanism only. |
| Darouei 2025 · Diabetol Metab Syndr | meta-analysis | mixed | moderate | Glycemic variability (MAGE, SD) predicted adverse cardiovascular events, but the pooled evidence came from patients with pre-existing cardiovascular disease rather than healthy people. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.